Skip to main content

Closed

RADX: Radiopharm Theranostics Limited Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

3thpctl

Volume

1.49×avg

Market Cap

4.06MUSD

P/E Ratio

-0.9TTM

Div Yield

-ann

Radiopharm Theranostics Limited

RADXNASDAQ Capital Market·USD·Closed

Radiopharm Theranostics Limited

RADXNASDAQ·USD·Closed

$3.15

−1.56%

$3.15

−$0.05 (1.56%)

52W Range

3thpctl

Volume

1.49×avg

Mkt Cap

4.06MUSD

P/E

-0.9TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings